May 9
|
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
|
May 8
|
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
|
May 8
|
Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term
|
May 7
|
Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
|
May 7
|
Best Value Stocks to Buy for May 7th
|
May 7
|
Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
|
May 7
|
Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)
|
May 6
|
3 Biotech Stocks to Double Your Money in the Next 24 Months
|
May 6
|
United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons Why
|
May 6
|
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock
|
May 6
|
United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run?
|
May 3
|
30 Most Profitable Companies with Highest Margins in the World
|
May 2
|
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
|
May 2
|
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript
|
May 2
|
United Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ...
|
May 2
|
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight
|
May 2
|
Q1 2024 United Therapeutics Corp Earnings Call
|
May 1
|
Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity
|
May 1
|
Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics
|
May 1
|
United Therapeutics Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
|